Download

Full Text

• Williams, M., Commentary: Fifty years exploring pharmacology with Sam Enna. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116067.
• Jarvis, M.F., Decatastrophizing research irreproductibility. Biochem. Pharm, 2024, 10.1016/j.bcp.2024.116090.
• De Clercq, E., A scientific career from the early 1960s till 2023: a tale of the various protagonists. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116248.
• De Clercq, E., Li, G., Zhang, Y., Huang, J., Tan, L., Unachieved antiviral strategies with acyclic nucleoside phosphonates: Dedicated to the memory of dr. Salvatore “sam” Joseph Enna. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116448.
• Kaur, G., Rahman, S., Shaikh, S., Panda, K., Chinnapaiyan, S., Santiago Estevez, M., Xia, L., Unwalla, H., Rahman, I., Emerging roles of senolytics/senomorphics in HIV-related co-morbidities. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116179.
• Fiorucci, S., Urbani, G., Biagioli, M., Sepe, V., Distrutti, E., Zampella, A., Bile acids and bile acid activated receptors in the treatment of Covid-19. Biochem. Pharm., 2024, 10.1016/j.bcp.2023.115983.
• Di Marco, T., Mazzoni, M., Greco, A., Cassinelli, G., Non-oncogene dependencies: Novel opportunities for cancer therapy. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116254.
• Jena, B.C., Flaherty, D.P., O'Brien, V.P., Watts, V.J., Biochemical pharmacology of adenylyl cyclases in cancer. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116160.
• Ghosh, N., Mahalanobish, S., Sil, P.C., Reprogramming of urea cycle in cancer: Mechanism, regulation and prospective therapeutic scopes. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116326.
• Zhao, J., Wu, S., Wang, D., Edwards, H., Thibodeau, J., Kim, S., Stemmer, P., Wang, G., Jin, J., Savasan, S., Taub, J.W., Ge, Y., Panobinostat sensitizes AraC-resistant AML cells to the combination of azacitidine and venetoclax. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116065.
• Russo, G.L., Spagnuolo, C., Russo, M., Reassessing the role of phytochemicals in cancer chemoprevention. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116165.
• Tu, H., Zhou, X., Zhou, H., Luo, Z., Yan, Y., Luo, Z., Qi, Q., Anti-tumor effect and mechanisms of Timosaponin AIII across diverse cancer progression. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116080.
• Li, Y., Guo, F., Wang, W., Lv, F., Zhang, L., Zhu, M., Yang, S., Dong, S., Zhou, M., Li, Z., Zhu, Z., Yang, J.-M., Zhang, Y., Marein, a novel natural product for restoring chemo-sensitivity to cancer cells through competitive inhibition of ABCG2 function. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116219.
• Xu, C., Pascual-Sabater, S., Fillat, C., Goel, A., The LAMB3-EGFR signaling pathway mediates synergistic anti-cancer effects of berberine and emodin in pancreatic cancer. Biochem. Pharm., 2024 no DOI available yet.
• Yang, L., Guttman, L., Dawson, V.L., Dawson, T.M., Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116174.
• Nelson, R.B., Rose, K.N., Menniti, F.S., Zorn, S.H., Hiding in plain sight: Do recruited dendritic cells surround amyloid plaques in Alzheimer's disease?. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116258.
• Coyle, J.T., Passing the torch: The ascendance of the glutamatergic synapse in the pathophysiology of schizophrenia. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116376.
• Uliana, D.L., Lisboa, J.R.F., Gomes, F.V., Grace, A.a., The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116298.
• Peng, L., Zhang, J., Feng, J., Ge, J., Zou, Y., Chen, Y., Xu, L., Zeng, Y., Li, J.-X., Liu, J., Activation of trace amine-associated receptor 1 ameliorates PTSD-like symptoms. Biochm. Pharm., 2024, 10.1016/j.bcp.2024.116236.
• Barrett, J.E., Kohut, A.R., A historical perspective and recent advances on the evolution of the relationship between acute and chronic pain and cardiovascular disease. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116357.
• Amodeo, G., Magni, G., Galimberti, G., Riboldi, B., Franchi, S., Sacerdote, P., Ceruti, S., Neuroinflammation in osteoarthritis: From pain to mood disorders. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116182.
• Lochhead, J.J., Ronaldson, P.T., Davis, T.P., The role of oxidative stress in blood–brain barrier disruption during ischemic stroke: Antioxidants in clinical trials. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116186.
• Witkin, J.M., Radin, D.P., Rana, S., Fuller, D.D., Fusco, A.F., Demers, J.C., Thakre, P.P., Smith, J.L., Lippa, A., Cerne, R., AMPA receptors play an important role in the biological consequences of spinal cord injury: Implications for AMPA receptor modulators for therapeutic benefit. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116302.
• Rodriguez-Contreras, D., García-Nafría, J., Chan, A.E., Shinde, U., Neve, K.A., Comparison of the function of two novel human dopamine D2 receptor variants identifies a likely mechanism for their pathogenicity. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116228.
• X. Gonda, F.I. Tarazi and P. Dome, The emergence of antidepressant drugs targeting GABA-A receptors: a concise review. Biochem. Pharm. (2024) No DOI number yet.
• Fritzius, T., Tureˇcek, R., Fernandez-Fernandez, D., Isogai, S., Rem, P.D., Kralikova, M., Gassmann, M., Bettler, B., Preassembly of specific Gβγ_subunits at GABAB receptors through auxiliary KCTD proteins accelerates channel gating. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116176.
• Rahman, S.N., Imhaouran, F., Leurs, R., Christopoulos, A., Valant, C., Langmead, C.j., Ligand-directed biased agonism at human histamine H3 receptor isoforms across Gαi/o- and β-arrestin2-mediated pathways. Biochem. Pharm., 2024, 10.1016/j.bcp.2023.115988.
• Roth, B.L., Krumm, B.E., Molecular glues as potential GPCR therapeutics. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116402.
• Dai, H.-C., Ji, R.-L., Tao, Y.-X., SHU9119 and MBP10 are biased ligands at the human melanocortin-4 receptor. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116325.
• Klausing, A.D., Fukuwatari, T., DeAngeli, N., Bucci, D.J., Schwarcz, R., Adrenalectomy exacerbates stress-induced impairment in fear discrimination: A causal role for kynurenic acid?. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116350.
• Wilkin, C., Piette, J., Legrand-Poels, S., Unravelling metabolic factors impacting iNKT cell biology in obesity. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116436.
• Chun, K.-S., Kim, E.-H., Kim, D.-H., Song, N.-Y., Kim, W., Na, H.-K., Surh, Y.-J., Targeting cyclooxygenase-2 for chemoprevention of inflammation-associated intestinal carcinogenesis: An update. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116259.
• Mazumder, S., Bindu, S., Debsharma, S., Bandyopadhyay, U., Induction of mitochondrial toxicity by non-steroidal anti-inflammatory drugs (NSAIDs): The ultimate trade-off governing the therapeutic merits and demerits of these wonder drugs. Biochem. Pharm, 2024, 10.1016/j.bcp.2024.116283.
• Alcaraz, M.J., Control of articular degeneration by extracellular vesicles from stem/ stromal cells as a potential strategy for the treatment of osteoarthritis. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116226.
• Iliaki, S., Kreike, M., Ferreras Moreno, N., De Meyer, F., Aidarova, A., Braun, H., Libert, C., Afonina, I.S., Beyaert, R., Polo-like kinase 1 (PLK1) is a novel CARD14-binding protein in keratinocytes. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116316.
• Lash, L.H., Renal Glutathione: Dual roles as antioxidant protector and bioactivation promoter. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116181.
• Uno, Y., Shimizu, M., Yamazaki, H., A variety of cytochrome P450 enzymes and flavin-containing monooxygenases in dogs and pigs commonly used as preclinical animal models. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116124.
• Uno, Y., Minami, Y., Tsukiyama-Kohara, K., Murayama, N., Yamazaki, H., Identification of cytochrome P450 2C18 and 2C76 in tree shrews: P450 2C18 effectively oxidizes typical human P450 2C9/2C19 chiral substrates warfarin and omeprazole with less stereoselectivity. Biochem. Pharm., 2024, 10.1016/j.bcp.2023.115990.
• Yabut, K.C.B., Wen, Y.W., Simon, K.T., Isoherranen, N., CYP2C9, CYP3A and CYP2C19 metabolize Δ9-tetrahydrocannabinol to multiple metabolites but metabolism is affected by human liver fatty acid binding protein (FABP1). Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116191.
• Ramachandran, A., Akakpo, J.Y., Curry, S.C., Rumack, B.H., Jaeschke, H., Clinically relevant therapeutic approaches against acetaminophen hepatotoxicity and acute liver failure. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116056.
• Choi, S., Ofosu-Boateng, M., Ki, S., Nnamani, D.O., Mah'moud, M., Neequaye, P., Gebreyesus, L.H., Twum, E., Gonzalez, F.J., Cui, J.Y., Gyamfi, M.A., Molecular targets of PXR-dependent ethanol-induced hepatotoxicity in female mice. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116416.
• Marin, J.J.G., Cives-Losada, C., Macias, R.I.R., Romero, M.R., Marijuan, R.P., Hortelano-Hernandez, N., Delgado-Calvo, K., Villar, C., Gonzalez-Santiago, J.M., Monte, M.J., Asensio, M., Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116166.
• Chandler, C.M., Nickell, J.R., Wilson, A.G., Culver, J.P., Crooks, P.A., Bardo, M.T., Dwoskin, L.P., Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116189.
• Alarcon-Śanchez, B.R., Idelfonso-García, O.G., Guerrero-Escalera, D., Pina-Vazquez, C., de Anda-Jauregui, G., Perez-Hernandez, J.L., de la Garza, M., García-Sierra, F., Sanchez-Perez, Y., Baltierrez-Hoyos, R., Vasquez-Garzon, V.R., Muriel, P., Perez-Carreon, J.I., Villa-Trevino, S., Arellanes-Robledo, J., A model of alcoholic liver disease based on different hepatotoxics leading to liver cancer. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116209.
• Budusan, E., Payne, C.D., Gonzalez, T.I., Obergrussberger, A., Becker, N., Clark, R.J., Rosengren, K.J., Rash, L.D., Cristofori-Armstrong, B., The funnel-web spider venom derived single knot peptide Hc3a modulates acid-sensing ion channel 1a desensitisation. Biochem. Pharam., 2024, 10.1016/j.bcp.2024.116175.
• Cirinciani, M., Da Pozzo, E., Trincavelli, M.L., Milazzo, P., Martini, C., Drug Mechanism: A bioinformatic update. Biochem. Pharm, 2024, 10.1016/j.bcp.2024.116078.
• Leahy, C., Osborne, N., Shirota, L., Rote, P., Lee, Y.-K., Song, B.-J., Yin, L., Zhang, Y., Garcia, V., Hardwick, J.P., The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116241.
• Govaere, O., Cockell, S.J., Zatorska, M., Wonders, K., Tiniakos, D., Frey, A.M., Palmowksi, P., Walker, R., Porter, A., Trost, M., Anstee, Q.M., Daly, A.K., Pharmacogene expression during progression of metabolic dysfunction-associated steatotic liver disease: Studies on mRNA and protein levels and their relevance to drug treatment. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116249.
• Chen, N., Luo, J., Zhou, T., Shou, Y., Du, C., Song, G., Xu, L., Zhao, K., Jin, Y., Li, C., Yu, D., Lysine β-hydroxybutyrylation promotes lipid accumulation in alcoholic liver disease. Biochem. Pharm., 2024, 10.1016/j.bcp.2023.115936.
• Trius-Soler, M., Moreno, J.J., Bitter taste receptors: Key target to understand the effects of polyphenols on glucose and body weight homeostasis Pathophysiological and pharmacological implications. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116192.
• Gan, P.X.L., Zhang, S., Wong, W.S.F., Targeting reprogrammed metabolism as a therapeutic approach for respiratory diseases. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.11618.
• Eltayeb, K., Alfieri, R., Fumarola, C., Bonelli, M., Galetti, M., Cavazzoni, A., Digiacomo, G., Galvani, F., Vacondio, F., Lodola, A., Mor, M., Minari, R., Tiseo, M., La Monica, S., Petronini, P.G., Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116161.
• Gonzalez-Candia, A., Figueroa, E.G., Krause, B.J., Pharmacological and molecular mechanisms of miRNA-based therapies for targeting cardiovascular dysfunction. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116318.
• Edin, M.L., Gruzdev, A., Bradbury, J.A., Graves, J.P., Muse, G.W., Goulding, D.R., Lih, F.B., DeGraff, L.M., Zeldin, D.C., Overexpression of soluble epoxide hydrolase reduces post-ischemic recovery of cardiac contractile function. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116237.
• Lin, C., Mazzuca, M.Q., Khalil, R.A., Vascular Surgery Research Laboratories, Division of Vascular and Endovascular : Increased uterine arterial tone, stiffness and remodeling with augmented matrix metalloproteinase-1 and -7 in uteroplacental ischemia-induced hypertensive pregnancy. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116227.
• Pannucci, P., Van Daele, M., Cooper, S.L., Wragg, E.S., March, J., Groenen, M., Hill, S.J., Woolard, J., Role of endothelin ETA receptors in the hypertension induced by the VEGFR-2 kinase inhibitors axitinib and lenvatinib in conscious freely-moving rats. Biochem. Pharm., 2024, 10.1016/j.bcp.2023.116007.
• Burgess, J.K., Gosens, R., Mechanotransduction and the extracellular matrix: Key drivers of lung pathologies and drug responsiveness. Biochem. Pharm., 2024, 10.1016/j.bcp.2024.116255.